pharma investment

Digital

Good healthcare has long been guided by strong ethics – this is nothing new and would not be a surprise to anyone reading this.

News

In its third big licensing deal of the week, Eli Lilly has tapped RNA-editing specialist Ascidian for kidney disease therapies in a $1.9bn alliance.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.